Genetic Associations of Inflammatory Cytokines and Gut Microbiota-derived Metabolites with Sepsis and Acute Kidney Injury: A Bidirectional and Two-step Mendelian Randomization Study
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background: Whether elevated cytokines and gut metabolites in sepsis and acute kidney injury (AKI) represent upstream contributors or downstream correlates of impaired renal clearance remains unresolved. Aims: To evaluate bidirectional and two-step mediated genetic associations of 21 cytokines and 21 gut metabolites with sepsis and AKI. Study Design: Two-sample bidirectional and exploratory two-step mediation Mendelian randomisation (MR) study (STROBE-MR). Place and Duration of Study: Summary-level analysis of SCALLOP (2023), YFS/FINRISK (2017), CLSA (2023), UK Biobank–FinnGen (2021), and FinnGen R12 (2024; analysed through October 2026). Methodology: GRCh38 instruments (per 1-SD biomarker or log-odds liability; F=20.4–5,240.6) from SCALLOP (N=14,824), YFS/FINRISK (N≤8,293), and CLSA (N=8,299) were tested against overlapping FinnGen R12 AKI (8,383/480,448) and sepsis (17,133/439,048; polygenic P<5×10-6, mean F=23.5) and UKB–FinnGen AKI (7,695/474,571), with MRlap, UKB sepsis, and eGFR-adjusted multivariable MR. Results: Only sepsis-to-AKI survived FDR correction (FinnGen polygenic OR=1.281, 95% CI 1.188–1.380, FDR=2.02×10-10; strict k=3 OR=1.298, 95% CI 0.963–1.751; UKB–FinnGen OR=1.188, 95% CI 1.044–1.352; non-overlapping UKB sepsis OR=1.214, 95% CI 1.068–1.380), exceeding reverse AKI-to-sepsis (Weighted Median OR=1.027). No biomarker survived FDR (BH-FDR=0.162–0.538) or replicated across both AKI datasets. Nominal AKI signals included IL-12B (OR=1.065, 95% CI 1.006–1.127), taurocholenate sulfate (OR=1.089, 95% CI 1.013–1.172), glycochenodeoxycholate 3-sulfate (OR=1.124, 95% CI 1.021–1.238), N-acetylkynurenine (OR=1.062), and butyrylcarnitine (OR=0.958, 95% CI 0.923–0.995); nominal sepsis signals included TRAIL (OR=1.094, 95% CI 1.024–1.168), 6-bromotryptophan (OR=1.091), CCL19 (OR=0.917, 95% CI 0.861–0.977), and cis-IL6R (OR=0.858; uncorrected pind=0.0135–0.0461, BH-FDRind≥0.0828). Uremic toxins, effector cytokines, and 14 reverse models were null. Conclusion: Genetic liability to sepsis is associated with AKI risk, whereas cytokine and gut metabolite signals represent exploratory, nominal leads that do not survive FDR correction.
Institutions: Sekolah Tinggi Ilmu Kesehatan Papua, Queensland Government
Language: English
Topic: Acute Kidney Injury Research
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7225982639
